Reference

·

Supporting source

Thailand Premium Smartwatch Installed Base

Apple Watch ~2.1M, Samsung Galaxy Watch ~1.4M, Huawei Watch ~0.8-1.2M

As ofFY2024 installed base·Sources4·Supporting

Apple Watch holds the Thai premium consumer smartwatch anchor at roughly 2.1 million installed base by FY2024 (Insight estimate triangulating Apple Thailand store presence, iCloud Thai subscriber base and IDC Asia Pacific quarterly wearables data); Samsung Galaxy Watch holds roughly 1.4 million installed base; Huawei Watch GT and Watch D combined run roughly 0.8 to 1.2 million. Apple Watch Series 10 retails at THB 14,900 to 26,900 in Thailand; Samsung Galaxy Watch7 at THB 11,900 to 17,900; Huawei Watch D continuous BP at THB 14,500 to 18,900. The 2027 angle is non-invasive optical glucose research convergence: when a consumer-grade non-invasive glucose feature ships in mass-market smartwatch hardware (Apple, Samsung or Huawei), the Thai CGM TAM expands roughly 6 to 10x by 2030 because pre-diabetic and Type-2 lifestyle-management buyers no longer need a sensor patch.

Figure in context

Apple Watch holds the Thai premium consumer smartwatch anchor at roughly 2.1 million installed base by FY2024 (Insight estimate triangulating Apple Thailand store presence, iCloud Thai subscriber base and IDC Asia Pacific quarterly wearables data); Samsung Galaxy Watch holds roughly 1.4 million installed base; Huawei Watch GT and Watch D combined run roughly 0.8 to 1.2 million. Apple Watch Series 10 retails at THB 14,900 to 26,900 in Thailand; Samsung Galaxy Watch7 at THB 11,900 to 17,900; Huawei Watch D continuous BP at THB 14,500 to 18,900. The 2027 angle is non-invasive optical glucose research convergence: when a consumer-grade non-invasive glucose feature ships in mass-market smartwatch hardware (Apple, Samsung or Huawei), the Thai CGM TAM expands roughly 6 to 10x by 2030 because pre-diabetic and Type-2 lifestyle-management buyers no longer need a sensor patch.

Apple Watch holds the Thai premium consumer smartwatch anchor at roughly 2.1 million installed base by FY2024 (Insight estimate triangulating Apple Thailand store presence, iCloud Thai subscriber base and IDC Asia Pacific quarterly wearables data); Samsung Galaxy Watch holds roughly 1.4 million installed base; Huawei Watch GT and Watch D combined run roughly 0.8 to 1.2 million. Apple Watch Series 10 retails at THB 14,900 to 26,900 in Thailand; Samsung Galaxy Watch7 at THB 11,900 to 17,900; Huawei Watch D continuous BP at THB 14,500 to 18,900. The 2027 angle is non-invasive optical glucose research convergence: when a consumer-grade non-invasive glucose feature ships in mass-market smartwatch hardware (Apple, Samsung or Huawei), the Thai CGM TAM expands roughly 6 to 10x by 2030 because pre-diabetic and Type-2 lifestyle-management buyers no longer need a sensor patch.

Time scope

FY2024 installed base

Source basis

Supporting source

Interpretation notes

What this tells you

Apple Watch holds the Thai premium consumer smartwatch anchor at roughly 2.1 million installed base by FY2024 (Insight estimate triangulating Apple Thailand store presence, iCloud Thai subscriber base and IDC Asia Pacific quarterly wearables data); Samsung Galaxy Watch holds roughly 1.4 million installed base; Huawei Watch GT and Watch D combined run roughly 0.8 to 1.2 million. Apple Watch Series 10 retails at THB 14,900 to 26,900 in Thailand; Samsung Galaxy Watch7 at THB 11,900 to 17,900; Huawei Watch D continuous BP at THB 14,500 to 18,900. The 2027 angle is non-invasive optical glucose research convergence: when a consumer-grade non-invasive glucose feature ships in mass-market smartwatch hardware (Apple, Samsung or Huawei), the Thai CGM TAM expands roughly 6 to 10x by 2030 because pre-diabetic and Type-2 lifestyle-management buyers no longer need a sensor patch.

What not to do with it

Use the linked report for interpretation and keep basis differences explicit.

Related figures

Adjacent numbers that add context without drowning the value.

2027 forecast
THB 9-15B by 2027 (vs THB 1.4-2.3B 2024)

Thailand CGM and Consumer Wearable Health-Tracker Market Size

Insight derivation from Abbott Form 10-K FY2024, DexCom Form 10-K FY2024, MoPH Diabetes Registry 2025, NHSO benefit schedule, IMARC Global CGM Market Report 2024, IDF Diabetes Atlas Thailand profile

FY2026-FY2027 OTC pricing
THB 1,950-2,800 per 14-day sensor (vs THB 4,800-6,500 prescription baseline)

Thailand CGM Sensor OTC Average Selling Price

Thai FDA Notification B.E. 2569, Abbott FreeStyle Libre 3 Thai product page, Dexcom Stelo product page, Roche Accu-Chek SmartGuide Thai launch, Boots, Watsons, Save Drug pharmacy channel checks

Effective Q3 2026 with full rollout FY2027
~80,000-130,000 sensor units per year (Type-1 plus gestational diabetes)

NHSO Universal Coverage CGM Reimbursement Volume

NHSO Notification on Universal Coverage Benefit Schedule, MoPH Thailand Diabetes Registry Annual Report 2025, Thai Diabetes Association position paper 2026

FY2025 published prevalence
5.2M diagnosed diabetics, 8.7M pre-diabetes, 62,000 Type-1, 78,000 annual gestational

Thailand Diabetes and Pre-Diabetes Prevalence

Ministry of Public Health Thailand Diabetes Registry Annual Report 2025, IDF Diabetes Atlas

FY2026-FY2027 three-channel pricing
NHSO THB 1,650-2,100, OTC THB 1,950-2,800, prescription THB 4,800-6,500

Thailand Abbott FreeStyle Libre 3 Three-Channel Pricing Spread

Abbott FreeStyle Libre 3 Thai product page, Thai FDA Notification B.E. 2569, NHSO benefit-schedule procurement, Krungthai Axa wellness-bundle 2026

FY2026 premium pricing
THB 24,000-58,000 annual (CGM, Oura Ring, Apple Watch subsidy bundled)

Krungthai Axa Wellness Bundle Premium Tier Annual Premium

Krungthai-AXA wellness-bundle 2026 product disclosure, Insight derivation from Bangkok Insurance and Dhipaya wellness tier announcements

Report context

Thailand CGM & Wearable Health Tracker 2027 Market Intelligence

Thailand has 5.2 million diagnosed diabetics and 8.7 million pre-diabetes (HbA1c 5.7 to 6.4 percent), with continuous glucose monitor (CGM) adoption (Abbott FreeStyle Libre 3, Dexcom G7, Medtronic Guardian Sensor 4, Roche Accu-Chek SmartGuide) and downstream consumer wearable health-tracker uptake (Oura Ring Gen4, Whoop, Apple Watch, Samsung Galaxy Watch, Huawei Watch D, Garmin Venu) compounding across 2026 to 2027. The 2026 to 2027 catalyst stack includes the NHSO Universal Coverage benefit-schedule bundling of CGM for Type-1 diabetics and gestational diabetes pregnancies (~80,000 to 130,000 reimbursed units) effective Q3 2026; the Thai FDA Q1 2026 over-the-counter reclassification of CGM sensors from Class III prescription-only to Class II pharmacist-counseling status, dropping sensor average selling price from THB 4,800 to 6,500 to THB 1,950 to 2,800; the Krungthai Axa, Bangkok Insurance and Dhipaya wellness-bundle premium tiers covering CGM, Oura Ring and Apple Watch; the Thai metabolic-health interpretation software layer (BeYou by Khon Kaen University, Glucose Goddess Thailand, Vata); the BOI Section 8 medical-device incentive plus corporate income tax deduction for employer-provided wearable wellness benefits; and the Apple, Samsung, Huawei consumer non-invasive glucose research pipeline approaching clinical accuracy by 2027 to 2028. Our read: the 2027 Thai CGM and consumer wearable health-tracker market reaches THB 9 to 15 billion (vs THB 1.4 to 2.3 billion in 2024), with Abbott, Dexcom, Medtronic, Apple, Samsung, Oura, Whoop and Garmin capturing roughly 80 percent share and Thai interpretation-layer brands (BeYou, Glucose Goddess Thailand) plus a parallel-import long tail capturing the remainder.

Open report →

Atlas actors in this figure's reports

Profiles covered in the report that cite this number.

Thailand Premium Smartwatch Installed Base · Insight